TW200612969A - 3-β-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof - Google Patents
3-β-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereofInfo
- Publication number
- TW200612969A TW200612969A TW094118512A TW94118512A TW200612969A TW 200612969 A TW200612969 A TW 200612969A TW 094118512 A TW094118512 A TW 094118512A TW 94118512 A TW94118512 A TW 94118512A TW 200612969 A TW200612969 A TW 200612969A
- Authority
- TW
- Taiwan
- Prior art keywords
- ribofuranosylthiazolo
- pyrimidine nucleosides
- compounds
- directed
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/018011 WO2005121162A1 (en) | 2004-06-07 | 2004-06-07 | 3-β-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200612969A true TW200612969A (en) | 2006-05-01 |
Family
ID=34959084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094118512A TW200612969A (en) | 2004-06-07 | 2005-06-06 | 3-β-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof |
Country Status (21)
Country | Link |
---|---|
US (1) | US20080070852A1 (zh) |
EP (1) | EP1758916B1 (zh) |
JP (1) | JP4856638B2 (zh) |
CN (1) | CN1964985A (zh) |
AR (1) | AR049203A1 (zh) |
AU (1) | AU2004320625B2 (zh) |
BR (1) | BRPI0418887A (zh) |
CA (1) | CA2566541C (zh) |
ES (1) | ES2399891T3 (zh) |
IL (1) | IL179529A0 (zh) |
IS (1) | IS8575A (zh) |
MX (1) | MXPA06014182A (zh) |
NO (1) | NO20070061L (zh) |
PA (1) | PA8635901A1 (zh) |
PE (1) | PE20060455A1 (zh) |
RU (1) | RU2006146204A (zh) |
SV (1) | SV2006002135A (zh) |
TN (1) | TNSN06403A1 (zh) |
TW (1) | TW200612969A (zh) |
UY (1) | UY28943A1 (zh) |
WO (1) | WO2005121162A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI407956B (zh) * | 2004-12-17 | 2013-09-11 | Anadys Pharmaceuticals Inc | 3,5-二取代和3,5,7-三取代-3H-唑并及3H-噻唑并〔4,5-d〕嘧啶-2-酮化合物及其前藥 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0009486D0 (en) | 2000-04-17 | 2000-06-07 | Univ Cardiff | Chemical compounds |
EP2007789B1 (en) | 2006-04-11 | 2015-05-20 | Novartis AG | Spirocyclic HCV/HIV inhibitors and their uses |
GB0609178D0 (en) * | 2006-05-09 | 2006-06-21 | Univ Cardiff | Novel compounds |
AR061024A1 (es) * | 2006-05-22 | 2008-07-30 | Novartis Ag | Maleato de 5-amino-3- (2'3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d] pirimidin-2-ona. |
BRPI0717741A2 (pt) * | 2006-10-17 | 2014-04-08 | Anadys Pharmaceuticals Inc | Compostos e respectivos método de preparação, método de redução de composto de sulfonil substituído, composição farmacêutica método de tratamento ou prevenção de doença |
PL2014771T3 (pl) * | 2007-06-25 | 2015-05-29 | Anadys Pharmaceuticals Inc | Ciągły proces hydrolizy enzymatycznej |
EP2019113A1 (en) * | 2007-07-26 | 2009-01-28 | Anadys Pharmaceuticals, Inc. | New Crystalline Salts of 5-Amino-3-(2',3'-di-O-acetyl-beta-D-ribofuranosyl)-3H-thiazolo[4,5-d]pyrimidin-2-one |
US8512690B2 (en) | 2009-04-10 | 2013-08-20 | Novartis Ag | Derivatised proline containing peptide compounds as protease inhibitors |
US20110182850A1 (en) | 2009-04-10 | 2011-07-28 | Trixi Brandl | Organic compounds and their uses |
KR101848099B1 (ko) * | 2009-09-21 | 2018-04-11 | 길리애드 사이언시즈, 인코포레이티드 | 1'-치환된 카바-뉴클레오사이드 유사체의 제조를 위한 방법 및 중간체 |
US9011833B2 (en) | 2010-10-08 | 2015-04-21 | Novartis Ag | Vitamin E formulations of sulfamide NS3 inhibitors |
CN102153548B (zh) * | 2011-02-24 | 2012-11-28 | 河北大学 | 一种含有噻唑(嗪)烷酮环的类核苷衍生物及其制备方法和其在药物制剂中的应用 |
WO2023196458A1 (en) * | 2022-04-06 | 2023-10-12 | VenatoRx Pharmaceuticals, Inc. | Orally-bioavailable nucleoside analogs |
CN116589606B (zh) * | 2022-12-01 | 2024-05-28 | 中国药科大学 | 一种丁酰化酵母葡聚糖及其制备方法、应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880784A (en) * | 1987-12-21 | 1989-11-14 | Brigham Young University | Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives |
US5041426A (en) * | 1987-12-21 | 1991-08-20 | Brigham Young University | Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides |
UA79764C2 (en) | 2001-11-27 | 2007-07-25 | Anadys Pharmaceuticals Inc | 3-?-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF |
-
2004
- 2004-06-07 AU AU2004320625A patent/AU2004320625B2/en not_active Ceased
- 2004-06-07 JP JP2007527161A patent/JP4856638B2/ja not_active Expired - Fee Related
- 2004-06-07 RU RU2006146204/04A patent/RU2006146204A/ru not_active Application Discontinuation
- 2004-06-07 BR BRPI0418887-0A patent/BRPI0418887A/pt not_active IP Right Cessation
- 2004-06-07 MX MXPA06014182A patent/MXPA06014182A/es not_active Application Discontinuation
- 2004-06-07 WO PCT/US2004/018011 patent/WO2005121162A1/en active Application Filing
- 2004-06-07 CN CNA2004800432620A patent/CN1964985A/zh active Pending
- 2004-06-07 US US11/570,209 patent/US20080070852A1/en not_active Abandoned
- 2004-06-07 ES ES04785930T patent/ES2399891T3/es not_active Expired - Lifetime
- 2004-06-07 EP EP04785930A patent/EP1758916B1/en not_active Expired - Lifetime
- 2004-06-07 CA CA2566541A patent/CA2566541C/en not_active Expired - Fee Related
-
2005
- 2005-06-06 SV SV2005002135A patent/SV2006002135A/es unknown
- 2005-06-06 TW TW094118512A patent/TW200612969A/zh unknown
- 2005-06-06 UY UY28943A patent/UY28943A1/es not_active Application Discontinuation
- 2005-06-07 AR ARP050102308A patent/AR049203A1/es not_active Application Discontinuation
- 2005-06-07 PA PA20058635901A patent/PA8635901A1/es unknown
- 2005-06-07 PE PE2005000655A patent/PE20060455A1/es not_active Application Discontinuation
-
2006
- 2006-11-23 IL IL179529A patent/IL179529A0/en unknown
- 2006-12-05 IS IS8575A patent/IS8575A/is unknown
- 2006-12-06 TN TNP2006000403A patent/TNSN06403A1/en unknown
-
2007
- 2007-01-04 NO NO20070061A patent/NO20070061L/no not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI407956B (zh) * | 2004-12-17 | 2013-09-11 | Anadys Pharmaceuticals Inc | 3,5-二取代和3,5,7-三取代-3H-唑并及3H-噻唑并〔4,5-d〕嘧啶-2-酮化合物及其前藥 |
Also Published As
Publication number | Publication date |
---|---|
JP2008501792A (ja) | 2008-01-24 |
AU2004320625B2 (en) | 2009-08-27 |
AR049203A1 (es) | 2006-07-05 |
EP1758916B1 (en) | 2012-11-21 |
WO2005121162A1 (en) | 2005-12-22 |
AU2004320625A1 (en) | 2005-12-22 |
EP1758916A1 (en) | 2007-03-07 |
RU2006146204A (ru) | 2008-07-20 |
CA2566541A1 (en) | 2005-12-22 |
IS8575A (is) | 2006-12-05 |
SV2006002135A (es) | 2006-05-08 |
MXPA06014182A (es) | 2007-06-25 |
US20080070852A1 (en) | 2008-03-20 |
UY28943A1 (es) | 2006-01-31 |
NO20070061L (no) | 2007-03-05 |
PE20060455A1 (es) | 2006-06-19 |
CA2566541C (en) | 2012-10-09 |
PA8635901A1 (es) | 2006-07-03 |
CN1964985A (zh) | 2007-05-16 |
IL179529A0 (en) | 2007-05-15 |
TNSN06403A1 (en) | 2008-02-22 |
ES2399891T3 (es) | 2013-04-04 |
BRPI0418887A (pt) | 2007-10-30 |
JP4856638B2 (ja) | 2012-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200612969A (en) | 3-β-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof | |
YU45204A (sh) | 3-BETA-D-RIBOFURANOZILTIAZOLO/4,5-d/ PIRIMIDINSKI NUKLEOZIDII NJIHOVA UPOTREBA | |
TNSN07208A1 (en) | 3,5-DISUBTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d] PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF | |
TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
TW200724543A (en) | Heterocyclic compounds and their uses as therapeutic agents | |
TW200716546A (en) | Oxindole compounds and their uses as therapeutic agents | |
TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
GB0222495D0 (en) | Compounds | |
TW200611695A (en) | Pyrrolopyridine derivatives | |
WO2004062625A3 (en) | Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease | |
WO2007100366A3 (en) | Quinolone m1 receptor positive allosteric modulators | |
UA83194C2 (ru) | Производные пиримидина и их применение как модуляторов св2 | |
EA200601212A1 (ru) | Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение | |
WO2005018545A3 (en) | Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease | |
MXPA05008438A (es) | Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6. | |
YU75603A (sh) | Dihidropirimidinska jedinjenja koja su supstituisana na cijano grupi i njihova upotreba u lečenju oboljenja | |
WO2002079149A3 (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
AU2003260436A1 (en) | Pyrimidine compounds | |
ATE451350T1 (de) | Arylalkylsulfonamide als therapeutische mittel zur behandlung von knochenleiden | |
TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
UA91697C2 (en) | 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF | |
WO2006110447A3 (en) | Pyrimidine derivatives and their use in the treatment of cancer | |
DOP2005000261A (es) | Compuestos de 3h-oxazolo y 3h-tiazolo [4,5-d] pirrimidin-2-ona 3,5-disustituida y 3,5,7-trisustituida y profarmacos de los mismo | |
UA87851C2 (ru) | Производные пирролотриазина, применимые для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом |